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      INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                              INTRODUCTION 
           Coronary artery disease is the leading cause of death globally
1
. In 2001 
coronary artery disease accounted for 7.1 million deaths world wide
2,3
, 80% of 
which were in low income countries like India
4
. It has been estimated that by 
2010, 60% of world’s heart disease are expected to occur in India5.Indians are 
prone to get coronary artery disease at an earlier age than do people in 
developed countries because of the high prevalence of  risk factors like diabetes 
and hypertension
6,7
.                      
           In Indian population ST segment elevation myocardial infarction is the 
most common type of acute coronary event and contributes to 60.6% of overall 
incidence of  acute coronary syndrome
8
.The overall mortality in STEMI is 
approximately 4 to 7 % or even less in the published clinical trials. However 
this is not the case in the real world  situation
9,10
 .This is because the patients 
enrolled in the randomized trials are selected ones and represented low-risk 
subgroup. Therefore the results of these trials are not applicable to 50% of 
patients in clinical practice
11
. 
            A realistic view can be obtained from registry data. In India, CREATE 
registry data recorded an in-hospital mortality rate of 7.9% and 30 day mortality 
rate of about 8.6%, which included both patients with unstable angina and AMI. 
V.Jacob Jose and Satya N. Gupta from Vellore (Tamilnadu), observed 16.9% in 
hospital mortality rates  among South Indian population  following  STEMI 
12
.
   
 
                Hyponatremia is a common electrolyte disorder amongst hospitalized 
patients
13,14,15,,16
,especially with heart failure, nephrotic syndrome or cirrhosis. 
             
              Hyponatremia has been shown to be a predictor of cardiovascular 
mortality among patients with heart failure
17,18,19
. In fact, the neurohormonal 
activation that accompanies acute myocardial infarction is similar to  that which 
accompanies  heart  failure
20
.               
           
                 Hyponatremia is common after MI
21
, and clinical improvement is 
accompanied by a rise in plasma sodium concentration
22
. However, while the 
prognostic value in hyponatremia in chronic heart failure is well 
established
23,24,25
, the prognostic importance of hyponatremia in the setting of 
acute myocardial infarction are lacking. 
                      
                This study was done to determine the prognostic importance of 
hyponatremia in the setting of acute ST elevation MI and to determine its 
usefulness in predicting short term survival. 
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                       AIMS  OF  THE   STUDY 
1. To  study the  prevalence of hyponatremia  in  acute  ST  elevation 
myocardial infarction. 
 
2. To study the relationship between severity of hyponatremia and  short 
term mortality.  
 
3. To  find out  the  prognostic  importance  of  hyponatremia in  acute  ST 
elevation  myocardial  infarction. 
 
 
4. To  assess  the  usefulness  of  hyponatremia  as an independent risk 
factor  in   predicting   short term  mortality. 
 
5. To find out the association between hyponatremia and other risk factors 
like  ejection fraction, hypertension, diabetes, smoking, age, sex and  type  
of  infarction. 
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                    REVIEW OF LITERATURE 
                          
                               ACUTE  MYOCARDIAL  INFARCTION 
MAGNITUDE OF THE PROBLEM: 
26
 
            Cardiovascular disease accounts for approximately 12 million deaths 
annually and to the common cause of death globally. Since past 3 decades there 
is considerable decline in incidence and prevalence of coronary artery disease in 
the industrialized western world, whereas it is increasing in the developing 
world.  
             Asian Indians, whether living in their own country or as immigrants 
have much higher incidence of coronary artery disease  as compared to all other 
ethnic groups. Coronary artery disease  among Asian Indians has been found to 
be more severe, diffuse and associated with serious complications and 
increasing mortality at a younger age. 
               In this ethnic group specific risk factors, infections and inflammations 
are emerging. An underlying genetic susceptibility associated with a specific 
abnormality in lipid profile and different lifestyle factors makes coronary artery 
disease  to assume a malignant course in Asian Indians. 
           
         
 
              In 1960 CAD represented 4% CVD deaths. In 1990 the proportion was 
greater than 50% of CVD deaths. CAD deaths rates currently are 3 times more 
than the stroke rates. However it may suggest metabolic differences in response 
to the urban life style, higher fat diets and lower levels of activity. Further more 
the proportion of calories derived from fat, much of which comes from dairy 
products, is significantly higher in India than in other parts of the developing 
world.  
CORONARY RISK FACTORS FOR ASIAN INDIANS
27 
        
Asians have different and specific risk factors as compared to western 
population. 
NON MODIFIABLE: 
Male age > 35 years 
Female age > 45 years 
Family history of premature CAD (at age < 55) 
MODIFIABLE (NONLIPID) 
Hypertension ,Cigarette  smoking ,tobacco abuse 
Diabetes mellitus / insulin resistance syndromes 
Apple obesity or body mass index > 22 
Homocysteine > 10 micro mol/lit 
High PAI-1 
 
 
MODIFIABLE (LIPID) 
Total cholesterol  > 150mg/dl 
Triglycerides  >  150 mg/dl 
LDL cholesterol  >  100 mg/dl 
APO – a lipoproteins  > 100 mg/dl 
HDL cholesterol < 40 mg/dl males, < 50 mg/dl females. 
MODIFIABLE LIPOPROTEIN RATIOS 
TC/HDLc  >  4.5 
LDLc/HDLc  >  3.5 
APO A/APO B  <  1.2 
LIPID TETRAD = (LPa *TG *LDLc) / HDLc > 20,000 
PATHOPHYSIOLOGY: 
28,29
 
                  Virtually all acute infarcts are caused by thrombosis developing on a  
ruptured atherosclerotic plaque. Such rupture leads to sudden occlusion of the 
vessel due to liberation of  rbc”s, platelets, macrophages, and subsequently lead 
to thrombus formation.  
CLINICAL PRESENTATION: 
30
 
               Pain is the most common presenting complaint  and  is  described as 
heavy, squeezing, crushing, stabbing or burning, lasting more than 30 minutes. 
Typically pain involves central portion of the chest or  epigastrium and often 
radiates to the arms.  
 
PHYSICAL FINDINGS: 
30
 
         Anterior infarction have sympathetic nervous system hyperactivity, 
tachycardia and hypertension. Patients with inferior wall infarction show 
evidence  of  parasympathetic  hyperactivity ,bradycardia  and  hypotension. 
            
         Precordium is usually quite and apical impulse may be difficult to palpate. 
Other physical signs are decreased intensity of S1, paradoxical splitting of S2, 
S3 or S4 may be heard. 
             
            In 1967, Killip
31
 proposed  a  prognostic  classification  scheme  in 
patients  presenting  with  acute MI.  
a) Class-I     patients are free of rales and a third heart sound.  
b) Class-II    patients  have  rales  <50%  of lung  fields, and  may or may not 
have  S3.  
c) Class-III   patients  have  rales  in  >50%  of  each  lung  field and frequently 
have  pulmonary  edema, S3  
d) Class-IV  patients  are  in  cardiogenic  shock.  
 
 
 
 
 
INVESTIGATIONS 
1) ELECTROCARDIOGRAM:
32
 
   A) REPOLARISATION (ST-T WAVE) ABNORMALITIES 
             When acute ischemia is transumural the overall ST vector is usually 
shifted in the direction of outer (epicardial) layers and ST elevation and 
sometimes tall positive (hyper acute) T waves are produced over the ischemic 
zone. Reciprocal ST depressions can appear in leads reflecting the contralateral 
surface  of  the  heart.  
    B) QRS CHANGES 
              Necrosis of sufficient myocardial tissue can lead to decreased R wave 
amplitude or Q wave in the anterior, lateral or inferior leads as a result of loss of 
electromotive forces in the infarcted area. 
             Abnormal Q waves can sometimes be associated with subendocardial 
infarcts and transmural infarcts can occur without Q waves. Loss of 
depolarization forces in these regions can reciprocally increase R wave in V1 
and  V2  rarely  without  causing  diagnostic  Q waves  in  any  of  the  leads. 
C) EVOLUTION OF ECG CHANGES : 
                 Ischemic ST elevation and hyper acute T wave occur within hours to 
days  followed by T wave inversion and sometimes Q waves in the same lead 
distribution. These ischemic changes are often associated with QT prolongation. 
T wave inversion can resolve after days  or  weeks or  persists  indefinitely. 
 
2)  LABORATORY FINDINGS  
 A]SERUM  MARKERS  OF  CARDIAC  DAMAGE: 
  I) CREATINE  KINASE  MB
33
 
         CK-MB starts to rise within 4 – 8 hours after the onset of infarction, peaks 
by 24 hours and declines to normal within 2-3 days.  
   II) CARDIAC SPECIFIC TROPONINS
33,34,35,36
 
           Both TnT and TnI first begin to rise above reference limit by 3 hours 
from the onset of chest pain, TnI peaks by 24 hours and persist for 7 – 10 days 
after AMI, elevation of TnT peaks by 12 hours to 2 days and may persist up to 
14 days. 
   III) MYOGLOBIN:
,33,34,35
  
     Peak levels of serum myoglobin are reached considerably earlier (1-4 
hours) than peak values of serum CK and its measurement has been suggested 
as a useful index of successful reperfusion, and even infarct size
33,34
.  
  IV)LACTATE  DEHYDROGENASE (LDH):  
 LDH  starts  to  rise  24-48  hours  after  the  onset  of  AMI, reaches a 
peak  by  3-6 days  and returns to normal levels 8-14 days after the infarction.  
V) NEWER  CARDIAC MARKERS UNDER DEVELOPMENT 
37,38
 
         1) Heart fatty acid binding proteins (HFABP),  
         2) Myosin light chains (MLC),Myosin heavy chains (MHC)   
         3) Glycogen-phosphorylase isoenzyme BB (GPBB)
 
.  
 
B] LIPID PROFILE 
         Lipid  profile  should  be  obtained  after  24 – 48 hours39,40,41 of  MI 
because, for 24  hours  total  cholesterol  and  HDL  cholesterol  remains at or 
near  baseline  and  generally  fall  after  that. 
 
C] OTHER  INVESTIGATIONS  
        1) LEUCOCYTOSIS
42
 
                  Leukocytosis develops within 2 hours after MI and reaches peak by 
2 days ,returns to normal  by one week.  
        
         2) ESR 
                  ESR is usually normal during 1st or 2 days after MI, rises to peak by 
4– 5 days and remains elevated for several weeks.  
         
        3) HEMATOCRIT 
                 Hemotocrit often rises following MI due to hemoconcentration. 
          
        4) CRP
43,44
 
               An elevated C-reactive protein (CRP) level appears to identify patients 
at increased risk of coronary heart disease. 
 
 
3) IMAGING 
A]  CHEST X-RAY 
           The degree of congestion and the size of the left side of the heart on the 
chest-film are useful for defining groups of patients with MI who are at 
increased risk of dying after the acute event . 
B]  2D ECHOCARDIOGRAPHY 
            Regional wall motion abnormalities, Ejection fraction estimation helps 
in establishing prognosis after MI. Echo aid”s in early detection of potentially 
viable but stunned myocardium , residual provocable ischemia, patients at risk 
of developing CCF and mechanical complications after MI. 
C] DOPPLER ECHOCARDIOGRAPHY 
              For assessment of blood flow in the cardiac chambers and across 
cardiac valves. Helps in detecting severity of MR or TR after MI, identification 
of site of acute ventricular septal rupture, quantification of shunt flow across the 
defect, and assessment of acute cardiac tamponade. 
D] NUCLEAR IMAGING
45
 
               Radionuclide angiography, perfusion imaging, infarct avid 
scintigraphy,positron emission tomography have been used to evaluate MI. 
Cardiac radionuclide imaging for the diagnosis MI is indicated when the triad of 
clinical history, ECG findings and serum markers are unreliable or unavailable. 
 
 
COMPLICATIONS OF MYOCARDIAL INFARCTION 
1. Left  ventricular  failure 
2. Hypotension 
3. Cardiogenic Shock 
4. Mechanical Complications, Free wall rupture, Rupture of interventricular 
septum, Rupture of papillary muscles. 
5. Mitral regurgitation 
6. Arrhythmias 
7 .Electrical instability – Ventricular premature complex,ventricular 
tachycardia, ventricular fibrillation. 
8. Pump failure / excessive sympathetic stimulation . 
9.Atrial fibrillation, Paroxysmal supraventricular tachycardia, sinus tachycardia. 
10. Bradyarrhythmias and conduction disturbances – Sinus bradycardia 
AV blocks and Intraventricular Blocks, Junctional escape rhythms. 
11. Others: Recurrent chest discomfort, pericardial effusion and pericarditis, 
Dressler’s syndrome,venous thrombosis and pulmonary embolism, Left 
ventricular aneurysm  . 
 
 
 
 
 
OUTCOME 
           Outcome in acute MI can be assessed in three phases:  
           in hospital,  early (< 30day)  and  late  (beyond 30 days )  
 
MORTALITY: 
           The overall mortality rate following STEMI is approximately 4-7% in 
the published clinical trials
9
.However, this is not the case in real world situation, 
which can be obtained from registry data
11
.In a study published in Scotland, the 
case fatality rate is about 22.2%
46
. In MITRA,MIR 
47
registry data from 
Germany, the overall mortality is around 15% .In India, CREATE registry data 
recorded 30 day mortality rate of about 8.6% in STEMI .Study from Vellore in 
South India, reported in hospital mortality of 16.9% in a group of 1320 patients 
with acute STEMI.  
 
MORBIDITY :  
         Patients with STEMI are having the maximum number of complications 
because of transmural involvement. Other factors responsible are larger size of 
infarct and absence of tissue perfusion at the microvacular level
48,49
 
                               
                              
 
 
                                   HYPONATREMIA 
DEFINITION
50
 
             Hyponatremia is defined as a serum sodium concentration of 
<135mmol/l  after the exclusion of “pseudo-hyponatremia”.  
 
ETIOLOGY
51,52,53,54
 
CAUSES OF HYPONATREMIA 
I. Normal plasma osmolality- 
1. Hyperlipidemia 
2. Hyperproteinemia 
3.Post transurethral resection of prostate 
PSEUDOHYPONATREMIA 
                Extreme elevations in plasma lipids or proteins increase the plasma 
volume and can reduce the measured plasma sodium concentration.The 
hyponatremia in this situation does not represent a decrease in extracellular 
sodium  relative  to  extracellular  water . 
II. Increased plasma osmolality- 
1.Hyperglycemia 
2.Mannitol 
 
 
III. HYPO OSMOLAL HYPONATREMIA 
A. PRIMARY  SODIUM  LOSS  (SECONDARY WATER GAIN) 
1. Integumentary loss: sweating, burns 
2. Gastrointestinal loss: vomiting, tube drainage, fistula, obstruction, diarrhea 
3. Renal loss: diuretics, osmotic diuresis, hypoaldosteronism, salt-wasting 
nephropathy, post obstructive diuresis, nonoliguric acute tubular necrosis. 
B. PRIMARY WATER GAIN (SECONDARY SODIUM  LOSS) 
1. Primary polydipsia 
2. Decreased solute intake (e.g., beer potomania) 
3. AVP release due to pain, nausea, drugs 
4. Syndrome of inappropriate ADH secretion 
5. Glucocorticoid deficiency 
6. Hypothyroidism 
7. Chronic renal insufficiency 
C. PRIMARY SODIUM  GAIN (EXCEEDED BY SECONDARY WATER 
GAIN) 
1. Heart failure 
2. Hepatic cirrhosis 
3. Nephrotic syndrome 
 
 NEUROHORMONAL ACTIVATION FOR HYPONATREMIA 
FOLLOWING ACUTE    MYOCARDIAL INFARCTION 
55
 
             
            In acute myocardial infarction, nonosmotic release of vasopressin may 
occur due to the acute development of left ventricular dysfunction, in response 
to pain, nausea
56
, and major stress, or in response to the administration of 
analgesics and diuretics
57
.  
            
             In this setting, vasopressin levels increase concomitantly with the 
activation of other neurohormones such as rennin and nor epinephrine
58
. 
However, vasopressin level does not correlate with serum osmolarity in 
myocardial infarction, suggesting that nonosmotic mechanisms are involved
59
. 
             
             Activation of carotid barorecepters has been implicated in the 
nonosmotic release of vasopressin due to arterial underfilling
59
.In addition, 
increased expression of messenger RNA for vasopressin in the hypothalamus 
has been described. 
             
            Moreover, the renal effect of vasopressin is enhanced in heart failure, as 
the vasopressin-regulated water in the collecting duct is up regulated
60  
.
 
                   
 In patients with myocardial infarction, hyponatremia may be aggravated 
further by the concomitant activation of the renin-angiotensin system and 
increased catecholamine production
61,62
. These factors decrease the glomerular 
filtration rate and subsequent delivery of tubular fluid to the diluting segment of 
the nehpron, further contributing to decreased renal water exertion. 
          
                Flear CT, Hilton P
22
 in their study of 235 patients admitted to a 
coronary care unit,concluded that hyponatremia, hypochloraemia, and uremia 
were common in patients with confirmed myocardial infarctions, the degree of 
infarctions correlating well with all the above indices of severity. They also 
found higher in-hospital mortality rates among patients with minimal plasma 
sodium levels  < 130mmol/L.  
            
                 Szatalowicz VL, Arnold PE, Chaimotivz C, Bichet D, Berl T, Schrier 
RW  in their study have shown that Vasopressin is essential for the development 
of hyponatremia and arginine vasopressin levels were detectable in 30 of 37 
patients with congestive heart failure. They also found that the degree of 
neurohormonal activation correlates with the severity of hyponatremia in 
patients with chronic heart failure
63
. 
           
 
 
          Sigurdsson A
20
, Held P, Swedberg K in their study of 55 patients with 
acute myocardial infarction concluded that sustained neurohormonal activation 
after myocardial infarction mainly occurs in patients with clinical heart failure 
and is related to the magnitude of myocardial damage, even in patients without 
heart failure. 
            
             Goldberg A et al
64
 in their study of 978 patients have concluded that 
early hyponatremia is a simple marker of neurohormonal activation during the 
acute phase of myocardial infarction and predicts the long-term development of 
heart failure and death .  
       
            Rouleau JL et al in their study of 534 patients have concluded that  
neurohormonal activation at the time of hospital discharge in post infarction 
patients is an independent sign of poor prognosis
65 
. 
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           MATERIALS AND METHODS 
        50 patients admitted to the intensive coronary care unit of Thanjavur  
medical college hospital between September 2009 and  October 2010, with 
acute ST elevation myocardial infarction (STEMI) were studied in a prospective 
manner. 
STUDY DESIGN: 
1) Single centred 
2) Prospective  
3) Follow up study 
Acute STEMI was diagnosed according to the following criteria. 
DIAGNOSIS OF STEMI: 
1. Presence of chest pain of >20min duration and 
2. ST segment elevation of >1mm in atleast two standard limb leads 
or >2mm in atleast two contiguous precordial leads or new onset of 
Left bundle Branch block and / or 
3. Elevated cardiac biomarkers. 
 
STUDY PARTICIPANTS: 
INCLUSION CRITERIA: 
           Patients who  presented within 12 hrs of onset of symptoms, with 
electrocardiographic evidence of STEMI,elevated cardiac biomarkers and 
received thrombolytic therapy with streptokinase were included in our study. 
EXCLUSION CRITERIA : 
1. Patients with Non STEMI or Unstable angina. 
2. People with previous history of coronary artery disease. 
3. People with previous history of arrhythmias. 
4. People with previous history of cardiomyopathy or heart failure. 
5.People with previous diuretic use. 
6.People with cirrhosis of liver,renal disease,hypothyroidism. 
7.Serum  Creatinine > 2mg% , Blood urea > 60mg/dl. 
          
         Patients who fulfilled the above inclusion criteria and not having any of  
the  above said  exclusion criteria were included in the study as a participant.  
 
 
METHODS 
       
             12 lead ECG was taken for all patients, Leads  V3R, V4R  was taken in 
patients with  inferior wall myocardial infarction.  
Location of the infarct were defined as follows 
Anteroseptal MI       :     ST elevation in V1 – V4  
Apical MI        :     ST elevation in V5 – V6 
Anterolateral MI       :    ST elevation in LI,avL,V4-V6           
Extensive Anterior wall MI  :    ST elevation in LI,avL,V1-V6  
Inferior wall MI       :    ST elevation in LII,LIII, aVF 
Right ventricular MI      :    ST elevation in V3R , V4R 
Posterior wall MI        :   Tall and wide R wave,  depressed and concave 
            upwards ST, upright and   widened T wave in V2. 
            The data regarding the baseline characters of the patients like age,  
gender,  smoking  habit,  diabetes  mellitus  and  hypertension  were  recorded. 
Hemodynamic status of the patient were assessed by recording  the   pulse ,   
blood   pressure,   jugular   venous   pressure   (JVP).   Careful  auscultation of  
cardiovascular, respiratory system was done to look for  the  presence of    S3, 
S4 gallop, murmur and crepitations.All  findings were  recorded.  
             Blood sugar, urea, creatinine and electrolytes were done for all  the 
patients at the time of admission. Chest X-ray, lipid profile was taken for all the 
patients before discharge.  
             Plasma sodium concentrations  were  obtained  on  admission and at 24, 
48 and 72 hours thereafter.For every 100mg/dl rise in blood sugar the plasma 
sodium was reduced  by 1.4 meq/dl. 
           All the patients were treated with antiplatelet drugs , sorbitrate ,morphine, 
atorvastatin ,ACE inhibitors, betablockers and with  accordance  to AHA /ACC   
guidelines  as  and  when  required  . 
           All   the  participants were put on continuous electrocardiographic 
monitoring for  24 hrs.12 lead ECG was  repeated one hour after thrombolysis , 
every 24 hrs ,and also whenever the situation demanded .  
           Hemodynamic status  was  assessed   at   regular  intervals   by   clinical   
methods.  Arrhythmias were recognized promptly with  continuous ECG  
monitoring and  confirmed with 12 lead ECG most of the time. Stable patients  
were  transferred  to the medical ward. Ejection Fraction, regional wall motion 
was  analysed  with echocardiogram.  
         After discharge the patients  were followed up in  the outpatient department 
weekly for 30 days. Morbidity, mortality data were  recorded  . 
 
STUDY END POINTS  
                The  primary  end  point  was   mortality within  30  days  following  
myocardial infarction.  Mortality data after discharge but within 30 days of 
myocardial  infarction  were  obtained  by telephone or postcard  returned 
by  patients  families or  reviewing  hospital  records. 
MEASUREMENT OF SERUM SODIUM 
          Plasma  sodium  concentrations  were  determined  by  using  an  ion  
selective electrode  auto analyzer (Roche OMNIC). Hyponatremia was defined 
as sodium level less than 135mmol/L (<135 mEq/L). 
 
STUDY PROTOCOL 
         Approval for this study was obtained from Research and ethical committee 
of Thanjavur Medical College, Thanjavur. Written and informed consent was 
obtained from all patients. Data were derived from patients by direct 
interrogation and examination. 
 
  STATISTICAL METHOD 
           All the data were analyzed with  SPSS software (version13.0) 
 Odd”s ratio,Confidence interval,Mean , standard deviation were calculated. 
Suitable parametric and non parametric tests  (Chi square test for non continuous 
variables,Analysis of variance for continuous variables  Z test ),  Univariate  and  
multivariate  logistic  regression  tests   were used to  determine the association  
between  hyponatremia  and  30-day  mortality.  
A probability value of <0.05 was considered statistically significant.                
                            
 
  
 
         RESULTS 
 
                          
 
 
 
 
 
 
 
 
             OBSERVATIONS AND RESULTS 
  
 TABLE NO 1 –AGE DISTRIBUTION  OF CASES                                      
 
 
 
 
 
 
 
 
GRAPH 1- AGE DISTRIBUTION                                        
 
  In our study majority of the cases were in the age group of 41-60.         
Minimun age was 29 ,maximum age was 80.  Mean age was 51.46, SD  12.8. 
2
11
12
12
11
3
NO OF CASES
21-30
31-40
41-50
51-60
61-70
71-80
 AGE NO OF  CASES PERCENTAGE 
21-30 2 4% 
31-40 11 22% 
41-50 12 24% 
51-60 12 24% 
61-70 11 22% 
71-80 2 4% 
SEX DISTRIBUTION OF CASES 
Table no 2 SEX DISTRIBUTION  OF  CASES 
S.no Content Males  Females 
1 Numbers 40 10 
2 Mean Age 51.35±12.8 52±13.4 
4 MEAN SODIUM LEVEL 136.8±3.2 135.7±3.7 
5 Death 8 3 
 
In our  study  80% were  males  and  20%  were  females.M:F-4:1. 
GRAPH 2 SHOWING SEX DISTRIBUTION  OF  CASES 
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TABLE -3 SHOWING  DISTRIBUTION OF RISK FACTORS 
S.No.  RISK FACTORS NO. OF CASES PERCENTAGE 
1 HYPERTENSION 22 44 % 
2 SMOKING 20 40 % 
3 DM 18 36 % 
 
GRAPH 3 SHOWING  DISTRIBUTION OF RISK FACTORS 
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TYPE OF STEMI: 
In our study, Anterior wall Myocardial infarction predominated followed 
closely by inferior wall myocardial infarction. 
TABLE-4  SHOWING TYPE OF STEMI: 
S.No Type No. of Cases Percentage Death 
1 AWMI 29 58 % 7 
2 ASMI 4 8 % 0 
3 ALMI 2 4 % 1 
4 IWMI 8 16 % 2 
5 IWMI+PWMI 5 10 % 1 
6 IWMI +RVMI 2 4 % 0 
 
GRAPH- 4 SHOWING  DISTRIBUTION OF  TYPE OF STEMI 
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OUR STUDY PATIENTS WERE DIVIDED INTO THREE GROUPS 
 Group  A  =   patients with normal sodium levels 
 Group  B  =   patients with hyponatremia on admission 
 Group  C  =   patients who developed hyponatremia within 72 hours 
All base line characteristics of the three groups were compared. 
TABLE 5 
GROUP NO.OF CASES 
A 35 
B 6 
C 9 
 
GRAPH 5 SHOWING NO.OF CASES IN EACH GROUP 
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GRAPH 6-MEAN  AGE  IN  STUDY  GROUPS 
 
               Patients  who  presented  with  hyponatremia  on  admission  (52±14)  
were of higher age when compared to patients with                                     
normal sodium levels  (50 ±12). 
GRAPH 7   SEXWISE  DISTRIBUTION IN STUDY GROUPS 
 
   As evidenced males constituted majority of the cases in all the three 
groups.There were 29 males in group A, 4 males in group B and 7 males  in 
group C.There were  6 females in group A, 2 in group B and  2 in  group C. 
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GRAPH 8-RISK  FACTORS  AMONG  THE THREE  GROUPS 
 
          
 
        67% were diabetic , 50% were smokers, 67% were hypertensives among 
patients who presented with hyponatremia on admission. 
        Among   patients who had normal sodium levels only 31% were diabetic, 
40%  were  smokers  and  40%  were hypertensive. The  proportion  of diabetic, 
hypertensive and smokers were  more among  patients  with  hyponatremia. 
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TABLE-6 TOTAL CHOLESTROL IN THREE GROUPS 
 
 
 
 
 
 
 
 
     The mean cholesterol was found to be 209.18mg/dl and S.D was 29.3 
GRAPH 9 -TOTAL CHOLESTROL IN THREE GROUPS 
 
Among patients who had total cholesterol >200 mg/dl 8 patients had 
hyponatremia.Only 5 patients in the hyponatremia group had total cholesterol 
<200mg/dl. 
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S. NO CONTENTS T.CH < 200 T.CH 200 – 
240 
T.CH > 240 
1 TOTAL CASES 23 17 10 
2 PERCENTAGE 46% 34% 20% 
3  GROUP A 18 15 5 
4 GROUP B 3 1 2 
5 GROUP C 2 2 3 
6 DEATH 4 3 4 
TABLE 7: LDL CHOLESTEROL LEVELS IN THREE GROUPS 
S.NO CONTENT   LDL < 100 LDL 100- 130 LDL >130 
1 total cases 14 22 14 
2 percentage 28% 44% 28% 
3 GROUP A 11 18 7 
4 GROUP B 2 2 2 
5 GROUP C 2 2 5 
6 Death 3 4 4 
GRAPH 10: LDL LEVELS AMONG THREE GROUPS 
 
       The mean LDL cholesterol was 115.3mg/dl. Levels > 130mg/dl were 
present in 28%. Among them 7 had normal sodium levels,2 had hyponatremia 
on admission and 5 developed hyponatremia within 72 hours.  
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 TABLE 8 : EJECTION FRACTIONS AMONG THREE GROUPS 
 
 
 
 
 
 
GRAPH 11: EJECTION FRACTION AMONG THREE GROUPS 
 
                       The mean ejection fraction was lower among patients who 
presented with hyponatremia or developed hyponatremia within 72 hours when 
compared with patients with normal sodium levels. 
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TABLE 9:KILLIP CLASS  AMONG THREE GROUPS 
KILLIP 
CLASS 
Normal sodium 
levels(n=35) 
 
Hyponatremia on 
admission 
(N=6) 
Hyponatremia 
within 72 hrs 
(N=9) 
DEATH 
CLASS I 28 (80 %) 4 (66%) 7 (77%) 6 (54%) 
CLASS II 6 (17%) 2 (33%) 1 (11%) 4 (36%) 
CLASS III 1 (2%) 0 1 (11%) 1 (9%) 
CLASS IV 0 0 0 0 
       A total of 6 patients with killip class I expired. Among them  4 had 
hyponatremia on admission and 2 developed hyponatremia within 72 hours and 
no deaths occurred in patients with normal sodium levels.4  patients with killip 
class II expired.Among them 2 patients had hyponatremia on admission ,           
1 patient  developed hyponatremia within 72 hours. 
GRAPH 12-KILLIP CLASS  AMONG THREE GROUPS 
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TABLE 10 
IN HOSPITAL COMPLICATIONS 
 
S. 
No 
Complication Count Percentage Death Mean Sodium 
Level Meq/l 
1 CCF 2 4% 1 133.75 
2 Acute MR 1 2% 1 129 
3 Pulmonary edema 2 4% 1 137.8 
5 Heart block 2 4% 0 138.25 
6 Ventricular 
Tachycardia 
 1 2% 0 134.25 
 
GRAPH 13-IN HOSPITAL COMPLICATIONS
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TABLE  11- SHOWING  MORTALITY  AMONG   THREE GROUPS 
 In our study, 35 patients had normal sodium levels,6 had hyponatremia on 
admission and 9 developed hyponatremia within 72 hours.The overall mortality 
rate was 22% (11 out of 50). 
GRAPH 14 - SHOWING   MORTALITY  AMONG  THREE GROUPS 
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PATIENTS 
35 6 9 50 
MORTALITY 4 5 2 11 
TABLE 12 COMPARING MORTALITY RATES AMONG THE THREE GROUPS 
GROUP MORTALITY RATES 
GROUP A 11.4% 
GROUP B 83.4% 
GROUP C 22% 
 
GRAPH 15  COMPARING MORTALITY RATES AMONG THE THREE GROUPS 
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TABLE 13 SHOWING SEVERITY OF HYPONATREMIA AND 
OUTCOME  IN TERMS OF  MORTALITY 
SODIUM LEVELS NO.OF CASES MORTALITY 
<130 MEQ/L 4 4(100%) 
131-134 MEQ/L 11 3(27.3%) 
   
    Among 4 patients with sodium level <130meq/l the mortality rate was 100%. 
11 patients had sodium levels between 131-134,out of which only 3 expired. 
 
GRAPH 16- SHOWING SEVERITY OF HYPONATREMIA AND 
OUTCOME  IN  TERMS  OF  MORTALITY 
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Table 14 SHOWING IN HOSPITAL AND POST DISCHARGE DEATH. 
 
       During the hospital stay three patients expired.Each group had one 
mortality.During follow up period three patients were re-admitted with post 
infarction failure and expired. Each group had one mortality. Out of the 
remaining 5 deaths ,2 patients belonged to group A and 3 belonged to group B. 
There was no mortality in group C . 
TABLE 15  SHOWING   CASES  READMITTED WITH  POST 
INFARCTION FAILURE AND DEATH.  
GROUP NO. OF CASES MEAN SODIUM  
Group A 1 141 
Group B 1 128.75 
Group C 1 133 
 
       As evidenced from the above table the mean sodium levels were low for 
patients who got re-admitted with  post infarction failure. 
 
 
 
S.NO NO .OF DAYS NO. OF DEATHS MEAN SODIUM 
1 <7 days 3 133.3 meq/l 
2 8-30 days 8 134.4 meq/l 
TABLE16-SHOWING BASE LINE CHARACTERISTICS OF 50 
PATIENTS 
 
          
                 All the baseline characteristics among the three groups of patients 
were compared. 
 
            
S.NO Characteristics 
 
Normal 
sodium 
levels(n=35) 
Hyponatremia 
on admission 
(N=6) 
Hyponatremia 
within 72 hrs 
(N=9) 
P value 
1 Age(yrs) 50  ±  12 
 
52  ±  14 47 ± 17 P=0.06 
2 Male sex 29(82%) 
 
 
4(67%) 7(78%) P=0.04 
3 Diabetes 11(31%) 
 
 
4(67%) 3(33%) P=0.03 
4 Smoking 14(40%) 
 
 
3(50%) 3(33%) P=0.05 
5 Hypertension 14(40%) 
 
 
4(67%) 4(44%) P=0.1 
6 Anterior wall 
infarction 
23(66%) 
 
 
4(67%) 8(89%)  
P=0.02 
7 T.Cholestrol 208.7±29.78 212±30.1 214±33.4 P=0.6 
8 S.ldl 114.5±20.8 121.5±31.3 122.4±29.4 P=0.3 
9 Killip class class I-28 
classII-6 
class III-1 
class I-4 
class II-2 
class III-0 
class I-7 
class II-1 
class III-1 
 
P=0.001 
10 Ejection 
fraction(%) 
54.4±10.7 43.33±7.68 47.33±15.57 P=0.001 
       Patients who presented  with  hyponatremia  on  admission  belonged to a 
higher age group  than  patients  with  normal  sodium  levels.   
      67%  of  patients  who  presented  with hyponatremia  on admission and 78% 
of patients  who  developed  hyponatremia  within 72hrs were  males.       
         Patients  who  presented  with  hyponatremia  or  developed  hyponatremia  
within  72  hours  more  often  were  smokers(67%)  and  had diabetes(67%), 
anterior infarction(67and89%), lower ejection fraction(43.33±7.68) when 
compared  to  patients  with  normal sodium  levels. 
    
 ODDS RATIO FOR 30 DAY MORTALITY 
 TABLE NO 17- ODDS RATIO- GROUP A VERSUS  OTHER  GROUPS 
 SURVIVORS NON 
SURVIVORS 
ODDS 
RATIO 
Z 
SCORE 
P 
VALUE 
GROUP  A 31 4    
GROUP  B 1 5 38.75 3.004 0.027 
GROUP  C 7 2 0.057 2.108 0.035 
        
         Odds  ratio  for  30  day  mortality  was  found  to  be  high  in   
hyponatremic  Group s (P=0.027 and 0.035) which is statiscically  significant. 
 
 
     TABLE NO 18 COMPARING SURVIVORS AND NON SURVIVORS 
S.NO Risk factors Survivors Nonsurvivors T or X
2
 P value 
 N 39 11   
1 Age(yrs)  
(mean 
±SD) 
 
48.89±11.6 55.1±17.9 1.382 0.173 
2 Sex M 
         F 
32(82%) 
7(18%) 
 
8(72%) 
3(27%) 
0.7 0.09 
3 Hyponatremia 
(mean 
±SD) 
 
 
135.02±1.65 130.9±2.7 6.29 0.001 
4 Smoking 12(61%) 8(72%) 0.09 0.7 
5 Diabetes   11(33%) 7(45%) 0.14 0.70 
6 Hypertension 14(36%) 7(63%) 1.5 0.2 
7 Infarct site 
Anterior 
 
Inferior 
 
 
17(43%) 
 
 
12(31%) 
 
8(72%) 
 
 
3(27%) 
 
 
1.8 
 
 
0.01 
 
0.17 
 
 
0.9 
8 T.Cholestrol 207.38±28.7 215.54±33.21 0.540 0.5 
9 S.LDL 113.28±20.8 122.5±25.8 0.53 0.3 
10 Killip class I 
                   II 
                   III     
33(85%) 
5(13%) 
1(2%) 
6(54%) 
4(36%) 
1(9%) 
0.62 0.04 
11 EF(%)(mean 
±SD) 
54.35±11.2 42.72±9.2 3.15 0.002 
 
          
 
               
      It  was  seen  that  serum  sodium  levels  was  statistically  significant  in  
determining  mortality.    Mean  serum  sodium  level was  135.02±1.65 in  the  
survivors and 130.9±2.7  in non survivors. 
       
            Other  factors  such  as  Killip  class, ejection fraction, hypertension,  
diabetes,  age  , sex,dyslipidemia  were  found  to influence  mortality. 
                
          Multivariate analysis and analysis of variance was performed which 
showed   that    along   with  other  risk  factors,  hyponatremia   on  admission  
(p<0.001)  or  early development  of  hyponatremia  (p<0.008)  is an 
independent  risk  factor  in  predicting  short  term  mortality. 
 
 
 
 
 
 
 
 
 
 
 
TABLE NO 19 SUMMARY OF RISK FACTORS IN PREDICTING 
MORTALITY 
                     
 
              As evidenced from the above table killip class,ejection fraction and 
hyponatremia on admission or early development of  hyponatremia significantly 
influenced mortality.Multivariate  analysis  showed  that  along  with  other  risk  
factors, hyponatremia was a significant  independent predictor of 30 day 
mortality.                                   
VARIABLE P VALUE 
AGE 0.1 
SEX 0.09 
SMOKING 0.7 
HYPERTENSION 0.7 
DIABETES 0.2 
DYSLIPIDEMIA 0.3 
KILLIP CLASS 0.04 
HYPONATREMIA ON ADMISSION 0.001 
HYPONATREMIA WITHIN 72 HOURS 0.008 
EF 0.002 
                                     
 
 
 
 
 
 
                      DISCUSSION 
          
 
 
 
 
 
 
 
 
 
                              DISCUSSION  
           In acute myocardial infarction the development of hyponatremia is a 
marker that probably incorporates different prognostic entities,including severe 
left ventricular dysfunction,hemodynamic alterations,and the extent of 
neurohormonal activation. 
          Goldberg A
66
 et al studied 1047 patients with acute ST elevation MI,  
without past history of heart failure.It was found that hyponatremia on 
admission or early development of hyponatremia was independently associated 
with short term mortality. 
AGE DISTRIBUTION IN MYOCARDIAL INFARCTION 
        Our study comprised of  50 pateints with acute ST elevation MI. The mean 
age was 51.4 ± 12.8 .Majority of the cases were in the age group of 41-60 . In 
the study conducted by Aziz M et al
67
 , the mean age was 57.28±6. In 
Goldberg”s study the mean age was 61±12.When compared to the other studies 
it is seen that Indians are prone to get MI at an earlier age. 
SEX DISTRIBUTION IN MYOCARDIAL INFARCTION 
           In our study, 80% were males and 20% were females.Simillar results 
were  seen in a studies conducted by  Aziz M et al, Goldberg A
66
 et al. Thus 
males are more prone to develop MI. 
 RISK FACTORS   IN MYOCARDIAL INFARCTION 
         In our study   20  patients were smokers, 22 were hypertensive and 18 
were diabetic.Among 11nonsurvivors,72% were smokers,63%  were 
hypertensive,45%  were diabetic.Killip and Norris et al 
68
in the Framingham 
heart study said that diabetes and smoking increases the risk of death after 
myocardial infarction.In GISS-2 trial
69
, out of 11483 hypertensive MI 
patients,3306 patients expired. Our study reveals that Diabetes,Hypertension 
and smoking are important risk factors in determining mortality. 
 
PREVALANCE OF HYPONATREMIA 
       In our study, hyponatremia was present on admission in 6 patients (12%). 
Hyponatremia developed in 9 patients(18%) during the first 72 hours of 
hospitalisation. In  a  study conducted by Goldberg A et
 
 al,hyponatremia was 
present in 131 patients (12.5%) and hyponatremia developed in 208(19.9%) 
during the first 72 hours of hospitalisation.Similar results were seen in the 
studies conducted by Flear CT et al ,Aziz M et al and Sushrat W et al
70
.          
Our results were also consistant with other studies.  
 
 
 
ASSOCIATION  BETWEEN HYPONATREMIA AND AGE 
         Patients who presented with hyponatremia on admission belonged to a 
higher age  (52 ± 14)  when compared to patients  with normal sodium levels 
who belonged to younger age (50 ±12). In the study conducted by Goldberg A,  
Hammerman H et al, mean age among patients with normal sodium levels was 
61±13 and hypontremic individuals was  63±13. 
  
 ASSOCIATION  BETWEEN HYPONATREMIA AND SEX 
        Males constituted majority of the cases .There were 29 males(82%) with 
normal sodium levels,4 males(67%) with hyponatremia on admission and 7 
males(78%) developed hyponatremia within 72 hours after admission.There 
were 6 females with normal sodium levels ,2 with hyponatremia on admission 
and 2 developed hyponatremia within 72 hours after admission.The higher male  
ratio was due to the fact that number of females were less in our study.Simillar 
results were found in Goldberg A , Hammerman H et al,Aziz M et al “s study. 
 
 
 
  ASSOCIATION  BETWEEN HYPONATREMIA,DIABETES,SMOKING 
AND HYPERTENSION. 
               Among  patients with normal sodium levels 31% were diabetic, 40% 
were  smokers and  40% were hypertensive.In patients who presented with 
hyponatremia on admission 67% were diabetic,50% were smokers,67% were 
hypertensive.In patients who developed hyponatremia within 72 hours after 
admission  33% were diabetic, 33% were smokers and 44% were hypertensive. 
Thus hyponatremia was more common among smokers,diabetic and 
hypertensive individuals.This is in accordance to the studies conducted by 
Goldberg A , Hammerman H et al,Aziz M et al,Hilis et al
71
.  
ASSOCIATION  BETWEEN HYPONATREMIA AND DYSLIPIDEMIA               
         54% of individuals had serum total cholesterol >200mg/dl.In  
hyponatremia group 8 patients  had total cholesterol >200 mg/dl and 5 patients 
had total cholesterol <200mg/dl..  
       7 patients  with normal sodium levels,2  patients with hyponatremia on 
admission and 5 patients with hyponatremia within 72 hours had  LDL 
levels>130mg/dl. Simillar results were found in Goldberg A , Hammerman H et 
al,Aziz M et al “s study. 
ASSOCIATION BETWEEN HYPONATREMIA AND ANTERIOR 
WALL INFARCTION            
       The incidence of anterior wall MI among patients with normal sodium 
levels,hyponatremia on admission and patients who developed hyponatremia 
within 72 hours was 66%,67% and 89% respectively.This was higher than the 
results of golberg”s study which was 37%,49% and 45% respectively. Studies 
done by Krumholz
72
 et al,Hillis et al also showed that  hyponatremia was 
common in anterior wall infarction. 
 
ASSOCIATION BETWEEN HYPONATREMIA AND KILLIP CLASS                
         66% of patients with hyponatremia on admission  belonged to killip class I 
and 33 %  belonged to killip class II.Among  patients with hyponatremia within 
72 hours ,77% belonged to killip class I, 11% belonged to class II and 11 % 
belonged to class III .Our results were similar to the studies done by Kerry Lee 
and Eric J Topol et al, Hillis et al and Goldberg A et el. 
 
 
 
 ASSOCIATION BETWEEN HYPONATREMIA AND EJECTION 
FRACTION            
         The mean ejection fraction was lower among patients who presented with 
hyponatremia( mean EF 43.33%) or developed hyponatremia within 72 
hours(mean EF 47.33%) when compared to patients with normal sodium 
levels(mean EF 54.4%). Our results were consistant with the study conducted 
by Goldberg A ,Hammerman H et al, were the mean EF among patients with 
normal sodium levels,hyponatremia on admission and hyponatremia within 72 
hours was 47%,42% and 42% respectively. 
 ASSOCIATION  BETWEEN HYPONATREMIA AND MORTALITY                                  
          The overall mortality rate in our study was 22%.Mortality among patients 
with normal sodium levels was 11 %,mortality with hyponatremia on admission  
was 83%,  and mortality with  hyponatremia within 72 hours was 22 % . 
         In study done by Goldberg et al, the overall mortality rate was 10% .        
Mortality among patients with normal sodium levels was 6.2%.With 
hyponatremia on admission  mortality was 20 %,  with  hyponatremia within 72 
hours mortality was 17 % . In comparision with the above study, our study had 
higher mortality in patients with hyponatremia on admission where as mortality 
was almost equal in patients who developed hyponatremia after admission. 
 ASSOCIATION  BETWEEN  SEVERITY OF HYPONATREMIA   AND 
MORTALITY                                 
      4 patients had a sodium level  of <130meq/l and the mortality rate was 
100%. Among  patients with sodium levels between 131-134meq/l,mortality 
was  27% (3/11 patients).In comparission with other studies by Goldber A,   
Aziz M et al  and Rahman et al 
73
our study had a higher mortality rate. 
  
     From our study it is evident that patients who presented with hyponatremia 
or developed hyponatremia early after admission were males belonging to a 
higher age group,had diabetes,hypertension,smoking history ,anterior infarction 
and lower ejection fraction. This is in accordance to the studies conducted by 
Goldberg A,Hammerman H et al,Aziz M et al. 
              
         It was seen that serum sodium levels was statistically significant in 
determining mortality. Among survivors mean serum sodium level was 
135.02±1.65 and lowest level was 133meq/l. Among non survivors  mean serum 
sodium level was 130.9±2.7 and lowest level was 127meq/l.         
       
       Multivariate analysis showed that hyponatraemia  on  admission  or early 
development of hyponatremia in patients with acute ST-Elevation MI appeared 
to be  a strong independent predictor of  short term mortality.  
     Prognosis worsens with increasing severity of hyponatraemia. Plasma 
sodium levels may serve as a simple marker to identify patients at high risk. 
                                                 
 
                                               
 
 
 
 
 
 
 
 
 
                                            
  
 
 
 
 
 
 
                          CONCLUSION 
 
 
 
 
 
 
 
 
 
 
                                             CONCLUSION 
1.  Asians are  prone to develop STEMI at a youger age than western   
population. 
2.  In Indians hypertension, smoking, dyslipidemia, diabetes are predominant  
risk   factors   for STEMI. 
3. Hyponatremia on admission or early development of hyponatremia within   
72 hours  was  associated  with  a  poor  prognostic  outcome. 
4. Severity of hyponatremia predicts mortality. 
 Sodium levels <130 meq/l was associated with 100%  mortality  when   
compared to levels between 131-134 meq/l which had a mortality rate of  27%. 
5. Patients with hyponatremia on admission or those who developed 
hyponatremia within 72 hours were males belonging to a higher age group, with 
lower ejection fraction, anterior wall infarction  and a higher proportion of them 
were smokers,hypertensive,diabetic  and  had  dyslipidemia. 
6. Along with other risk factors, hyponatremia on admission or early 
development of hyponatremia appeared to be a significant independant risk 
factor in  predicting  short  term  mortality  in  acute  myocardial  infarction. 
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HYPONATREMIA - A  PREDICTOR OF SHORT TERM                                                                                
MORTALITY  IN  ACUTE  ST- ELEVATION MYOCARDIAL                 
INFARCTION 
                                                           PROFORMA 
NAME:                           AGE:         IP NO:                       DOA              DOD 
ADDRESS: 
PRESENTING COMPLAINTS: 
A. CHEST PAIN:  
B. BREATHLESSNESS: 
C. COUGH 
D. PALPATION 
E. SYNCOPE 
F. SWELLING OF LEGS/ FACE 
G. NAUSEA /VOMITING 
RISK  FACTORS-DIABETES          /HYPERTENSION                 / SMOKER 
GENERAL PHYSICAL EXAMINATION 
VITAL SIGNS     Pulse          Blood pressure 
 SYSTEMIC EXAMINATION 
CVS   -                                            RS   - 
ABDOMEN -                                  CNS- 
KILLIP CLASS- 
INVESTIGATIONS 
1) TROPONIN T.                                             
2)BIOCHEMISTRY 
RBS         mg/dl    BLOOD UREA         mg/dl            S.CREATININE      mg/dl 
SERUM SODIUM LEVELS 
ADMISSION 24HRS 48 HRS 72HRS 
    
 
TOTAL CHOLESTEROL        mg/dl 
HDL CHOLESTEROL             mg/dl 
LDL CHOLESTEROL             mg/dl 
VLDL CHOLESTEROL          mg/dl 
TRIGLYCERIDE                     mg/dl 
IV.ELECTROCARDIOGRAPHY 
V.ECHOCARDIOGRAPHY- EJECTION FRACTION 
DIAGNOSIS 
 
IN HOSPITAL COMPLICATIONS 
 
DISCHARGE STATUS 
 
FOLLOW UP UPTO 30 DAYS 
                             
 
 
 
 
 
         ABBREVIATIONS 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
                           LIST OF ABBREVIATIONS 
AMI               : Acute myocardial infarction 
AVP              : Arginine Vasopressin 
CAD             :Coronary Artery Disease 
CCF              : Congestive Cardiac Failure 
CK-MB        : Creatinine Kinase-MB 
CVD             :Cardiovascular diseases 
ECG             : Electrocardiogram 
IHD              :Ischemic Heart Disease 
LVF             : Left ventricular Failure 
MR               :Mitral Regurgitation 
TR                :Tricuspid Regurgitation 
DM              :Diabetes mellitus 
AWMI         :Anterior wall myocardial infarction 
ASMI          :Antero septal myocardial infarction 
IWMI          :Inferior wall myocardial infarction 
RVMI         :Right ventricular myocardial infarction 
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1 RAMAN 46 M 1106537 N N N N N 56 141 141 140 141 150 90 96 24 0.9 178 95 2 AWMI 2*HB A
2 RAVI 43 M 1106476 N N N N N 61 140 140 139 139 136 72 102 28 0.8 190 102 1 IPWMI A
3 JAYAKUMAR 53 M 1101866 Y Y N N N 66 139 137 137 138 150 100 118 30 1 224 121 1 IWMI A
4 PETCHIUTHU 60 M 1101698 N Y N N N 46 138 138 137 139 140 90 137 29 0.9 267 120 2 AWMI A
5 MUTHUKANAN 50 M 1102302 N N N N N 58 139 138 140 139 100 72 166 28 0.8 186 80 1 AWMI A
6 ELANGOVAN 60 M 1061420 N Y N N N 42 137 136 137 138 160 100 87 24 0.7 210 100 1 AWMI A
7 SENTHILKUMAR 36 M 1047146 Y N Y N N 67 137 138 138 137 136 80 189 34 1.2 225 134 2 AWMI A
8 RAMADAS 68 M 1078786 N N N N N 56 133 134 134 134 100 70 112 31 1 188 108 3 AWMI CCF A
9 PANJACHARAM 64 M 1077103 N Y N N N 47 137 134 134 132 180 110 121 24 1 256 178 1 IWMI A
10 SHANKAR 40 M 1077000 N N N N N 67 138 135 137 138 124 70 109 37 1.4 192 98 1 ASMI A
11 NALLAIYAN 62 M 1076625 Y Y N N N 39 137 133 133 133 160 100 204 28 0.8 250 144 1 IWMI A
12 JEEVANANDAM 58 M 1077934 N N N N N 55 137 138 138 137 130 80 78 38 1.6 214 120 1 IPWMI A
13 DHANAPAL 49 M 1078088 Y N Y N N 41 128 129 130 129 126 72 156 34 1.2 184 92 2 AWMI ACUTE MRD
14 KALIYAPERUMAL 50 M 1078984 Y Y Y N N 36 129 130 130 129 170 110 216 21 0.9 255 164 1 IPWMI D
15 GUNASEELAN 58 M 1079500 Y N Y N N 69 136 137 141 139 112 80 125 29 0.9 178 95 1 AWMI A
16 RAJKANA 32 M 1109871 N N N N N 72 138 138 137 138 130 80 136 28 0.8 232 126 1 ALMI A
17 JAYSHANKAR 32 M 1080069 N N N N N 51 137 141 138 137 110 80 108 24 0.7 174 96 1 AWMI A
18 DEVAN DOSE 39 M 1080653 N N N N N 39 140 137 137 138 130 90 128 34 1.2 166 86 2 IWMI A
19 BOOMINATHAN 47 M 1080575 Y Y Y N N 43 128 130 129 128 150 90 178 22 0.6 189 91 1 IWMI D
20 MATHIMALAR 32 F 1081069 N N N N N 62 138 135 135 136 120 70 118 27 1 256 142 1 AWMI A
21 JOHN 50 M 1081601 N Y N N N 31 136 137 141 139 140 90 156 31 1 210 126 2 AWMI PE A
22 KAMU 67 F 1081833 Y Y N N N 49 137 135 136 137 90 60 312 24 1 194 102 1 AWMI A
23 VARADARAJAN 52 M 1082084 Y Y Y N N 57 139 138 138 137 200 110 279 32 1.1 203 112 1 AWMI A
24 NAMACHIVAYAM52 M 1082123 N N N N N 68 136 134 133 134 112 76 90 30 1 145 89 1 IWMI VT A pif
25 AMMAPONNU 63 F 1081168 N N N N N 61 136 137 141 139 110 80 87 29 0.9 253 146 1 ALMI 2*HB A
26 GOVINDARAMAN68 M 1083137 N Y Y N N 56 137 138 138 137 160 100 114 28 0.8 224 114 2 IWMI PE D
27 SUNDARAMBAL 65 F 1083386 Y N N N N 48 141 142 141 141 110 80 224 24 0.7 151 94 2 AWMI D PIF
28 SEKAR 30 M 1083397 N N N N N 47 136 132 133 133 110 80 107 38 1.6 225 140 1 AWMI A
29 NAGENDRAN 41 M 1041359 N Y Y N N 68 139 139 137 138 160 100 120 34 1.2 192 112 1 IRWMI A
30 THENNAMBAL 60 F 1041489 N N N N N 37 140 140 139 139 120 70 106 35 0.9 198 110 1 AWMI A
31 NILSON RAJA 45 M 1041870 Y N Y N N 46 136 134 133 134 120 70 267 29 0.9 224 112 1 AWMI A
32 BALA SARASWATHY34 F 1041954 N N N N N 59 137 133 131 133 110 80 77 28 0.8 215 107 1 AWMI A
33 AMUDHA 45 F 1042057 N N N N N 61 136 133 133 134 110 80 99 24 0.7 182 88 1 ASMI A
34 VELUSAMY 80 M 1043460 N N Y N N 55 139 141 142 143 120 70 113 34 1.2 227 128 2 AWMI D
35 SENTHILKUMAR 29 M 1043529 N N Y N N 35 137 141 138 137 112 76 86 38 1.6 236 138 1 AWMI A
36 GEETHA 60 F 1043828 N N N N N 52 137 138 138 137 112 76 90 34 1.2 171 95 1 IWMI A
37 ILAMPARUTHI 39 M 1044596 N N Y N N 59 140 140 139 139 112 76 109 35 0.9 210 114 1 IPWMI A
38 STEPHEN RAJ 47 M 1044607 N Y Y N N 71 138 138 137 138 160 100 256 34 1.2 195 98 1 AWMI A
39 KANNAN 37 M 1045032 N N Y N N 63 137 141 138 137 130 80 127 31 1 176 102 1 AWMI A
40 KANNAIYAN 40 M 1043238 Y Y N N N 42 140 137 137 138 130 80 142 24 1 242 138 1 ASMI A
41 ANBALAGAN 68 M 1045422 N Y Y N N 48 138 141 140 141 170 110 116 37 1.4 244 141 1 AWMI D
42 RAVI CHANDRAN 45 M 1046425 N Y Y N N 50 137 141 138 137 130 80 105 28 0.8 205 102 1 AWMI A
43 EMMARASAN 70 M 1046540 Y Y Y N N 30 137 134 132 132 80 60 112 34 1.2 190 105 3 AWMI CCF D
44 MARUTHAIYAN 76 M 1047055 Y N Y N N 29 137 133 131 131 110 80 117 38 1.6 250 144 1 ASMI D PIF
45 KARRUPUSAMY 58 M 1047154 N N Y N N 43 140 140 139 139 130 80 98 34 1.2 192 98 1 AWMI A
46 ANNAMALAI 56 M 1096709 Y Y N N N 57 136 137 141 139 130 80 218 35 0.9 228 136 1 IPRVMI A
47 SUMATHI 38 F 1095661 N Y N N N 36 133 132 132 134 130 80 131 31 1 214 120 1 AWMI D
48 MURUGAIYAN 62 M 1096328 Y N N N N 67 137 141 138 137 170 110 189 24 1 180 98 1 IPWMI A
49 NAGAMMAL 55 F 1096497 Y Y N N N 48 127 129 129 130 170 110 146 34 1.2 243 154 1 AWMI D PIF
50 MOHAN 62 M 1078418 Y Y Y N N 44 140 140 139 139 190 100 98 35 0.9 226 110 1 AWMI A
               KEY TO MASTER CHART 
DM                :Diabetes  mellitus 
HT                 : Hypertension 
CAD              :  Coronary  artery  disease 
EF                  : Ejection fraction 
SBP               : Systolic  blood  pressure 
DBP              : Diastolic  blood pressure 
RBS              : Random  blood sugar 
2*HB            : Second degree heart block 
CCF              :Congestive cardiac failure 
PE                 :Pulmonary edema 
VT                : Ventricular tachycardia 
PIF                :Post infarction Angina 
A                  :Alive 
D                  : Death 
AWMI         : Anterior wall myocardial infarction 
ASMI          : Antero septal myocardial infarction 
IWMI          : Inferior wall myocardial infarction 
RVMI          : Right ventricular myocardial infarction 
 
 
